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Ultrasound (US) is a well-established screening tool for detection of abdominal aortic 
aneurysms (AAAs) and is currently recommended not only for those with a relevant family 
history but also for all men and high-risk women older than 65 years of age. The advent 
of minimally invasive endovascular techniques in the treatment of AAAs [endovascular 
aneurysm repair (EVAR)] has increased the need for repeat imaging, especially in the 
postoperative period. Nevertheless, preoperative planning, intraoperative execution, and 
postoperative surveillance all mandate accurate imaging. While computed tomographic 
angiography and angiography have dominated the field, repeatedly exposing patients to 
the deleterious effects of cumulative radiation and intravenous nephrotoxic contrast, US 
technology has significantly evolved over the past decade. In addition to standard color 
duplex US, 2D, 3D, or 4D contrast-enhanced US modalities are revolutionizing AAA 
management and postoperative surveillance. This technology can accurately measure 
AAA diameter and volume, and most importantly, it can detect endoleaks post-EVAR 
with high sensitivity and specificity. 4D contrast-enhanced US can even provide hemo-
dynamic information about the branch vessels following fenestrated EVARs. The need 
for experienced US operators and accredited vascular labs is mandatory to guarantee 
the reliability of the results. This review article presents a comprehensive overview of 
the literature on the state-of-art US imaging in AAA management, including post-EVAR 
follow-up, techniques, and diagnostic accuracy.
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inTRODUCTiOn
Abdominal aortic aneurysm (AAA) currently is increasingly recognized as a significant cause of 
sudden death. AAAs are usually asymptomatic, and rupture has a mortality rate between 70 and 
90% and is roughly 40% for those who survive to undergo surgery (1). Its incidence closely follows 
atherosclerosis and hypertension in cardiovascular mortality with just under 10,000 annual deaths 
in the United States attributed to aortic aneurysm or dissection (2). Population adjusted mortal-
ity is higher in the UK with over 5,500 annual deaths (3). Differences in reporting standards and 
prevalence of risk factors, most notably smoking, are likely the major contributors to the disparity.
Currently, measurement of aneurysm diameter is the clinically approved tool for their diagnosis, 
and a cutoff of 5.5 cm is used as threshold for intervention, be it open or endovascular. The advent of 
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endovascular technology revolutionized AAA repair, decreasing 
perioperative morbidity and mortality, but this came at the cost of 
long-term complications and the need for life-long imaging sur-
veillance. Patients are subjected to repeated exposures to X-rays: 
before [pre-operative computed tomographic angiography 
(CTA)], during (perioperative fluoroscopy and angiography), and 
after the procedure (postoperative and follow-up CTA). This con-
tinuous radiation exposure has raised concerns both for patients 
and vascular surgical teams (4–6). Additionally, the intravenous 
iodinated contrast required for CTAs can have deleterious effects 
on patients who at baseline have an impaired renal function (7).
Ultrasonography has been well established for AAA screening 
as it is fast, cost-effective, and free of radiation exposure as well 
as side effects; it is increasingly entering the field of periopera-
tive and postoperative AAA care. Ultrasound (US) technology 
has significantly evolved over the past decade. In addition to 
standard color duplex ultrasonography (CDU), 3D, 4D, and 
contrast enhancement are revolutionizing AAA management and 
postoperative surveillance. This new technology can accurately 
measure not only AAA diameter but also volume, wall stress, and 
hemodynamic parameters, and is effective at detecting endoleaks 
after endovascular aneurysm repair (EVAR) (6, 8–11). This review 
article presents a comprehensive overview and analysis of the 
literature on the state-of-art US imaging in AAA management, 
including EVAR follow-up, techniques, and diagnostic accuracy.
nOveL ULTRASOUnD TeCHnOLOGieS
Ultrasonography of the aorta is primarily performed to detect 
or exclude the presence of a AAA. Conventional CDU is the 
cornerstone of screening and simple visualization of target ves-
sels. It is cheap and readily available, and poses no risk to the 
patient. Limitations of US technology include its limited ability 
to accurately visualize the aortic aneurysm or a stent in patients 
who are very obese, have extensive wall calcification, subcutane-
ous emphysema, significant bowel gas, ascites, or a large ventral 
hernia (11). The resolution of the image can be improved when 
patients follow a low residual diet the day before and fast on the 
day of testing (12). While commonplace usage of CDU continues, 
newer technologies have vastly furthered the reach of US tech-
nology with sensitivities and specificities of some of the newer 
imaging modalities matching or exceeding those of CTA and MR 
angiography (MRA) (13).
Contrast enhancement has vastly improved the resolving 
capabilities of US. US contrast agents are gas-filled microbubbles 
that are injected into the blood stream serving as intravascular 
reflectors of US waves. First-generation contrast enhancement 
involved the use of CO2 bubbles as a contrast medium, but this 
has been wholly supplanted by sulfur hexafluoride gas with a 
phospholipid shell which, as it degrades, is cleared by the lungs 
(6). This contrast is safe for patients with impaired renal function 
and requires no testing or monitoring prior to administration 
(6). Contrast-enhanced ultrasound (CEUS) allows improved 
visualization of the aortic lumen and delineation of thrombotic 
material on the arterial wall in real time. As contrast enhance-
ment improves resolution and it is capable to visualize the 
endograft from different angles demonstrating flow direction and 
velocity, CEUS is evolving as an attractive alternative for EVAR 
 surveillance (see EVAR Surveillance).
Three-dimensional ultrasound (3D US) technology has 
recently emerged as an alternative to CTA technology. The prin-
ciple of 3D reconstruction allows measurement of the maximum 
diameter perpendicular to the centerline of the AAA. 3D acquisi-
tion consists of an electronic sweep acquiring multiple images 
simultaneously in both longitudinal and transverse directions, 
with the transducer in a stable firm position and the patient hold-
ing his/her breath. The multiple planes are collected simultane-
ously, obviating the need for manual rotation of the probe with 
the associated possible loss of the target area of interest (11). The 
images that are obtained are processed with a 3D-specific software 
and can be enlarged, rotated, and analyzed in coronal, sagittal, 
and transverse planes akin to CT images (11). Speckle-tracking 
imaging is a post-processing method to further analyze data. The 
image processing algorithm automatically subdivides the region 
of interest into numerous small overlapping cubes with a volume 
of approximately 1 cm3. Every cube incorporates specific 3D gray 
scale image data, and cube displacement is tracked during the 
heart cycle (14). Four-dimensional ultrasound (4D US) is a term 
used to highlight the fact that this imaging modality provides a 
real-time moving 3D image of the area of interest. A 3D system 
can be added to many conventional probes and may also be com-
bined with CEUS to reproduce a high-contrast 3D image. The use 
of non-nephrotoxic contrast media in conjunction with 3D probe 
guidance and reconstruction allows for real-time interrogation 
from any angle with sensitivity and specificity matching those of 
CTA and MRA (11, 13).
Strain field mapping is a novel technology that aims to analyze 
localized wall strain. Traditional strain mapping, or wall stress 
analysis, of AAAs is based on CT and MRI. US has significant 
advantages in both radiation exposure, cost, and, in the case of 
MRI, accessibility and patient tolerance. Approaches on how 
a model of wall strain is quantified vary. Enhancement with 
contrast in combination with post-processing analysis can yield 
a highly spatially resolved strain field (14). Other approaches 
use real-time three-dimensional (3D) speckle-tracking US to 
non-invasively describe individual wall motion (kinematics) of 
the infrarenal aorta with a high spatial and temporal resolution 
(8). This allows the strain on an area of interest to be compared 
to the mean as a local strain ratio (15). US has been found to 
have good correspondence both with prior USs and to correlate 
well with CT and MRI findings (10). While not yet equivalent, it 
is hoped that refinement of the algorithms will further increase 
the spatial resolution of US technology (10). The significance of 
this technology has yet to be fully elucidated, but the aim is to 
eventually correlate the values with rupture risk.
SCReeninG
For ease of use, low cost, and lack of radiation exposure, sonogra-
phy is the well-validated highly sensitive (94–100%) and specific 
(98–100%) testing modality of choice for screening AAAs 
(16, 17). Evidence supports the use of anteroposterior rather than 
transverse measurements. Conventional US diameter measure-
ment is reliable from clearly insonated parts of the aneurysm wall, 
3Scaife et al. Ultrasound Applications in AAA Management
Frontiers in Surgery | www.frontiersin.org May 2016 | Volume 3 | Article 29
which explains why the anteroposterior axis is better; transverse 
measurements have otherwise worse reproducibility (18). Both 
the external and the internal diameter may be measured (see 
Need for Accredited Labs). The evidence for upper threshold for 
AAA surveillance (5.5-cm diameter) was based on the measure-
ment of external aortic diameter, but screening trials have also 
used the internal diameter (19, 20). 3D US is emerging as an even 
more accurate modality as it can estimate the AAA diameter 
perpendicular to the centerline as well as the AAA volume (21).
While there is no study demonstrating a significant difference 
in all-cause mortality between screened and unscreened men, 
there is evidence of a reduction in AAA-specific mortality by 
incorporating one-time ultrasonography screening among men 
aged 65–75 years who have ever smoked. There is no clear evidence 
to support general screening in women, as their low prevalence of 
AAA and worse outcomes associated with surgical intervention 
appear to outweigh any benefit. Controversy remains regarding 
AAA screening for men who have never smoked, women who 
have smoked, or have other significant risk factors for AAA. 
Current societal guidelines strongly recommend a screening 
US for male smokers 65–75  years, males with family history 
>50 years, while the recommendation for females is weaker, and 
it is only for those >65 years with multiple risk factors, smokers, 
or with a family history (19, 20, 22–28).
wALL STReSS AnALYSiS  
AnD RiSK ASSeSSMenT
Current guidelines for repair center solely around aneurysm size, 
for which CDU or simple 2D ultrasonography are the corner-
stone of most population-based screening programs; however, it 
makes intuitive sense that local wall abnormalities may prove to 
be independent contributors to the risk of rupture. Subjects with 
aneurysm diameters well under 5.0 cm can also rupture, whereas 
large aneurysms (> 10-cm diameter) may very well remain intact 
until death from other causes, indicating that the nature of the 
aneurysm wall may be more important than its size. Wall stress 
analysis has been introduced to predict the potential rupture risk 
of the AAA wall and is mostly performed using CT and scarcely 
by MRI. 3D US imaging overcomes the disadvantages of CT 
(radiation and contrast) and enables the possibility to acquire 
the vessel’s motion during the cardiac cycle. Coupled with post-
collection US speckle software analysis to delineate local foci of 
wall abnormalities and motion deformations, wall finite element 
models can be calibrated to the vessel motion, and thereby, more 
patient-specific material properties can be derived (8, 10, 14). 
While only the subject of small studies and, thus far, lacking in 
studies of reproducibility and clinical significance, this novel 
technology has the power to allow for a high-resolution mapping 
of wall motion and strain abnormalities within an aneurysm. The 
drawbacks of 3D US are the low contrast compared to CT, which 
can be resolved using CEUS, and the limited field-of-view (FOV), 
which may otherwise be of minor importance (8, 10, 14, 29).
Hemodynamic variables have been also linked with aneurysm 
growth and rupture. Liu et  al. developed the so-called echo 
particle image velocimetry (PIV) (30). They combined US with 
microbubbles acting as flow tracers in several cardiovascular 
models, including an AAA model. The authors managed to 
accurately measure several different complex flow patterns, such 
as vorticity, stagnation, and recirculation. Zhang et al. performed 
a preliminary in vivo study using this technique in five human 
carotid arteries (31). Optical PIV is currently the gold standard for 
wall shear rate (WSR) and wall shear stress (WSS) measurement.
It is foreseeable that this technology may permit future further 
stratification of AAA risk and serve as an important additional 
determinant of the need for intervention in addition to the 
presently used metrics. It is hoped that combining 3D speckle 
tracking with finite element analysis may permit the detection 
of local aortic wall abnormalities that either precede aneurysm 
formation or portend such to rupture.
PRe- AnD inTRAOPeRATive USe 
OF ULTRASOUnD FOR evAR
Computed tomographic angiography remains the modality of 
choice for accurate pre-operative planning. 3D reconstruction and 
consistency of measurements are as of yet unlikely to be replaced 
by the use of ultrasonography. Intraoperative use of CEUS has, 
however, been suggested as a means of reducing nephrotoxic 
contrast in patients with impaired renal function (32, 33). While 
CO2 angiography has been widely used in this subset of patients 
for arterial navigation and endograft deployment, it is generally 
inadequate for completion imaging (11, 32, 33).
A recent study suggested that intraoperative 3D CEUS 
imaging can accurately identify the renal arteries and endoleaks 
immediately after stent graft deployment. Furthermore, 3D 
CEUS imaging may detect and characterize endoleaks not seen 
on uniplanar angiography, including clinically important type I 
endoleaks, and has advantages over 2D CEUS imaging in inflow 
vessel identification and image manipulation (11) (Figure  1). 
The application uses magnetic field emitters to precisely posi-
tion the US probe and interrogate an endograft from any angle 
within the aneurysm. Simultaneous multiplanar data acquisition 
allows for rapid image acquisition and subsequent high-resolu-
tion reconstruction of the target vessel. When combined with the 
use of CO2, 3D CEUS can provide satisfactory completion imag-
ing and reduce the exposure to both radiation and nephrotoxic 
contrast during EVAR (11).
evAR SURveiLLAnCe
As the durability of open aneurysm repair is well established, 
surveillance after the 1-month follow-up is only recommended in 
regular 5-year intervals to exclude a paraanastomotic aneurysm. 
This is typically done using CDU (27, 28).
Post-EVAR surveillance recommendations, however, have 
undergone significant updates, based on the relatively higher 
anticipated long-term complication and reintervention rates. 
Original practice guidelines included a postoperative 30-day 
CTA study, repeated at 6 months, 1 year, and annually thereafter. 
There is increasing evidence of the need to decrease the imaging 
frequency. Specifically, elimination of the 6-month follow-up 
FiGURe 1 | Three-dimensional contrast-enhanced ultrasound done intraoperatively for completion imaging after evAR. A type I endoleak (arrow) as 
seen on the Curefab CS system workstation (Curefab, Munich, Germany) that was not identified on uniplanar angiography. Reprinted from Ormesher et al. (11), 
Copyright 2014, with permission from Elsevier.
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study, and substitution of the CTA beyond, or even at, 1 year with 
CDU has been suggested (34). The follow-up protocol remains 
ill defined when a type II endoleak is diagnosed. Although cur-
rent guidelines suggest CTA at 6 months upon type II endoleak 
detection at the postoperative CTA study, accumulating evidence 
suggests that omission of this follow-up visit and repeated imag-
ing at 12 months with CTA or CDU (combined with radiographs 
to assess migration or fracture) or non-contrast-enhanced 
computed tomography to check for sac growth with subsequent 
annual CDU is adequate, provided the sac does not expand (34).
Color duplex ultrasonography is not only cheaper and safer 
than other modalities but also may actually be more sensitive 
in the diagnosis of endoleaks, although the latter assertion 
remains controversial (12). Detection of type II endoleaks can 
be challenging and, not infrequently, they can be missed (low 
flow) or may overlap with other types of endoleaks and cannot 
be differentiated by CTA. Duplex US allows an extended period 
of observation; thus, it has the specific advantage of detecting not 
only low flow but also flow direction and characterizing the type 
of endoleak (Figure 2). Doppler waveforms may even predict the 
natural history of a type II endoleak. Color Doppler US has a 
reported sensitivity of 62–100% and specificity of 90–97% (12, 
35, 36). CDU is capable of detecting both Type I and III endoleaks 
(37), and follow-up protocols based on abdominal radiography 
and CDU have been demonstrated to be feasible, safe, and associ-
ated with substantial annual cost savings (35, 38–40).
Contrast-enhanced ultrasound is an evolving technology that 
significantly increases the diagnostic resolution of ultrasonog-
raphy and its ability to diagnose and detect endoleaks (41–45). 
Additionally, the spatial tracking and 3D reconstruction afforded 
by a 3D system allows for greater reproducibility and decreases 
operator dependency and intraobserver variability as well as 
provides a greater field of resolution (11, 34). CEUS has been 
found equivalent to CTA in endoleak detection in a number of 
studies with many authors going so far as to advocate the replace-
ment of CTA with CEUS in the post-procedural surveillance of 
an aneurysm and detection of endoleaks (34, 38, 41–43). In the 
postoperative evaluation of novel grafts, such as fenestrated endo-
vascular aneurysm grafts, 4D CEUS was found equivalent to CTA 
in assessing diameter, volume, endoleaks, as well as revascularized 
vessel patency (9). In those instances where traditional follow-up 
imaging modalities have failed to resolve the issue, CEUS provides 
an important adjunct (46, 47). It has the capacity to define a previ-
ously unclassified type of endoleak (34), visualize endoleak not 
previously visualized (46), and confirm vessel patency following 
fenestrated repairs. While the technology carries some inherent 
limitations which cannot be overcome, the combination of low 
price, no nephrotoxic contrast media or radiation exposure, 
reproducibility, and diagnostic accuracy equal to or greater than 
the current gold standard (CTA), CEUS will likely replace routine 
CTA as the first-line post-EVAR surveillance modality.
neeD FOR ACCReDiTeD LABS
Ultrasound use is largely operator and equipment dependent. 
If the technique is not reproducible, it will never enter clinical 
practice. This makes standardization of results and especially 
AAA measurements difficult to achieve. Certification of all 
involved professionals by accredited institutions and vascular labs 
is essential in minimizing variability. Vascular labs should always 
report interobserver and intraobserver variability alongside their 
results.
The task of AAA surveillance is complicated by the lack of 
standardization in measurement criteria. Conventional duplex 
US is documented as accurately measuring AAA diameter to 
within 3  mm of surgical specimens (13). When compared to 
FiGURe 2 | evAR follow-up, type ii endoleak detection by color Doppler ultrasound. (A) Aortic cross-sectional view showing right and left limb with a 
hypoechoic right posterior channel within the aortic thrombus, color Doppler filling of this channel confirms the presence of an endoleak; (B) spectral analysis 
indicates bidirectional flow along the right posterior margin of the aorta consistent with a type II endoleak from a patent lumbar artery; (C) aortic cross-sectional view 
showing right and left limb and an anterior flow channel; and (D) spectral analysis indicates bidirectional flow at the anterior margin of the aorta consistent with a 
type II endoleak from the inferior mesenteric artery.
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CT, US consistently reports smaller measurements (48–51). 
Additional confusion stems from a lack of standardization of 
measurement criteria, with outer to outer wall, outer to inner 
wall, and inner to inner wall measurements all having been used 
(52). Outer to outer wall measurements are the ones more closely 
correlated with CT findings (52). The discrepancy seems to be 
resolved with 3D CEUS, as numerous studies have demonstrated 
strong correlation with CTA measurements (9, 36, 43, 48, 52).
Along the same lines, as previously reported, it appears clear 
that for the foreseeable future, post-EVAR surveillance will involve 
a multi-modality approach to graft imaging (42, 53, 54). As CTA 
is increasingly supplemented or replaced by US modalities, use 
of an accredited vascular lab with experienced technologists and 
internal quality controls allows for validation and concordance 
between measurements.
COnCLUSiOn
Ultrasound is a cheap, accessible, and accurate screening tool for 
the previously undetected AAA, and is the imaging modality of 
choice in this setting. Novel technologies, including new ways 
of assessing wall strain and motion abnormalities, while not yet 
validated, have the future potential to allow for refinement of 
the rupture risk assessment beyond a simple size or ratio-based 
criteria. Future protocols may be refined to reflect local aortic 
wall motion and strain abnormalities for both development and 
rupture risk of AAA.
With the adoption of CEUS and 3D systems capable of spatial 
resolution, concurrent multiplanar data acquisition and recon-
struction in transverse, coronal, and sagittal planes, US use is 
likely to increase in the pre-operative assessment, intraoperative 
use, and postoperative EVAR surveillance. Sensitivity and speci-
ficity of CEUS now match that of the traditional gold standards 
CTA and MRA in the post-EVAR evaluation of the aortic sac and 
endoleak presence. While not all patients will be candidates due 
to the limitations inherent in US technology, those who are will 
benefit from a decreased exposure to radiation and nephrotoxic 
contrast.
Ultrasound technology has the potential to supplement and 
potentially supplant CTA in many protocols, as recommenda-
tions are updated to reflect its evolving capabilities. As US tools 
evolve, we will continue to see a shift toward greater integration 
with, and replacement of, existing imaging modalities in the 
management of AAA.
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